JPS588037A - Preparation of eicosapentaenoic acid or its ester - Google Patents

Preparation of eicosapentaenoic acid or its ester

Info

Publication number
JPS588037A
JPS588037A JP10320781A JP10320781A JPS588037A JP S588037 A JPS588037 A JP S588037A JP 10320781 A JP10320781 A JP 10320781A JP 10320781 A JP10320781 A JP 10320781A JP S588037 A JPS588037 A JP S588037A
Authority
JP
Japan
Prior art keywords
urea
distillate
main fraction
ester
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10320781A
Other languages
Japanese (ja)
Other versions
JPH0525870B2 (en
Inventor
Takao Fujita
藤田 孝夫
Masahiro Makuta
幕田 昌弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissui Corp
Original Assignee
Nippon Suisan Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Suisan Kaisha Ltd filed Critical Nippon Suisan Kaisha Ltd
Priority to JP10320781A priority Critical patent/JPS588037A/en
Priority to US06/329,883 priority patent/US4377526A/en
Publication of JPS588037A publication Critical patent/JPS588037A/en
Publication of JPH0525870B2 publication Critical patent/JPH0525870B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)

Abstract

PURPOSE:To obtain the titled compound economically with a little amount of wastes on an industrial scale, by distilling a mixture of fatty acids obtained from a natural fat or oil continuously, collecting a main fraction distillate containing the titled compound, and treating the resultant main fraction of ditillate with urea. CONSTITUTION:A natural fat or oil containing a large amount of eicosapentaenoic acid or a derivative thereof, e.g., a fat or oil of an animal marine plankton such as an antarctic krill (Euphausia superba) or a blue skinned fish such as a sardine or saury, is converted into the free fatty acid or an ester thereof by the conventional method, e.g. the saponification or alcoholysis, and the resultant product is then distilled continuously to collect a main fraction of distillate containing 40wt% or more titled substance. The main fraction of distillate is then treated with urea to remove low unsaturated fatty acids. The distillation is preferably carried out by using two packed or spring type rectifying columns in combination having the number of theoretical plates of 3-5 to remove the initial distillate in one of the columns and collect the main fraction of distillate in the other for about 40-60min respectively.

Description

【発明の詳細な説明】 本発明はエイコサペンタエン酸またはそのエステルの新
規な製法、更に詳細にはエイコサペンタエン酸又はその
誘導体を含む天然油脂から工業的規模で高濃度のエイコ
サペンタエン酸又はそのエステルを製造する方法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a novel method for producing eicosapentaenoic acid or its ester, and more specifically, a method for producing eicosapentaenoic acid or its ester in high concentration on an industrial scale from natural fats and oils containing eicosapentaenoic acid or its derivatives. Relating to a method of manufacturing.

エイコサペンタエン酸(以下、KX’Aと略称すること
もある)及びそのエステル、アミド等は心筋梗塞、脳梗
塞勢の血栓性疾患の治療及び予防化有効であることが既
tこ知られている(4!開昭55−15444号)。
It is already known that eicosapentaenoic acid (hereinafter sometimes abbreviated as KX'A) and its esters, amides, etc. are effective in treating and preventing thrombotic diseases such as myocardial infarction and cerebral infarction. (4! Kaisho 55-15444).

1P−人は天然油脂、特にサバ、イワシ、タラ等の水産
物油脂中をこそれ自体あるいはそのグリセライド等の誘
導体として含有されているが、他の夾雑する脂肪酸の方
が圧倒的に多い。而して、11iPムは上記の如き薬理
効果が認められているが、医薬品として布上されるため
には、多くの基礎研究及び臨床研究が行われなければな
らないが、このためには純度の高いEPAが大量に提供
されることが必要である。しかし、天然油脂から高濃度
の11iPムを工業的に分離する方法は、現在見出され
ておらず、これがKPAの医薬品としての開発の大きな
隘路となっていた。
1P-human is contained in natural oils and fats, particularly in marine oils and fats such as mackerel, sardines, and cod, either as such or as derivatives such as glycerides, but other contaminating fatty acids are overwhelmingly present. Although 11iPmu has been recognized to have the above-mentioned pharmacological effects, a lot of basic and clinical research must be conducted before it can be marketed as a drug. It is necessary that high EPA be provided in large quantities. However, a method for industrially separating high-concentration 11iPm from natural oils and fats has not yet been found, and this has been a major bottleneck in the development of KPA as a drug.

従来から、脂肪酸あるいはそのエステルの混合物から特
定の脂肪酸を濃縮するには、原料脂肪酸混合物の組成を
勘案して脱ロウ法、向流分配法、尿素付加法、蒸留法、
液体クロマトグラフ法等が用いられてきた。しかしこれ
等の方法は、脂肪酸の中でも比較的低分子の脂肪酸の分
離、或いは飽和酸と不飽和酸との区分けに用いられてき
た方法である。
Conventionally, in order to concentrate a specific fatty acid from a mixture of fatty acids or their esters, dewaxing method, countercurrent distribution method, urea addition method, distillation method,
Liquid chromatography and the like have been used. However, these methods have been used to separate relatively low-molecular-weight fatty acids among fatty acids, or to classify saturated acids and unsaturated acids.

ところがEPAは炭素数20ケ、二重結合5ケを持つ高
度不飽和脂肪酸で、その構造から云っても酸素、光、熱
等に不安定な物質であり、その定量法自体ガスクロマト
グラフィー技術の進歩により、ごく最近確立された脂肪
酸であって、前述の既存技術では容易にまた経済的に濃
縮分離することは困難である。
However, EPA is a highly unsaturated fatty acid with 20 carbon atoms and 5 double bonds, and its structure makes it unstable to oxygen, light, heat, etc., and its quantitative method itself requires gas chromatography technology. Due to advances, fatty acids have only recently been established and are difficult to concentrate and separate easily and economically using the existing techniques mentioned above.

前述の既存技術の中で、例えば、向流分配法、液体クロ
マトグラフィーがEPAの分離に利用できると思われる
が、これは数多い溶剤を大量に必要とし、しかも処理時
間が長く、経済的実用性から見た場合、全く意味のない
方法である。
Among the existing techniques mentioned above, for example, countercurrent distribution method and liquid chromatography can be used to separate EPA, but these require a large amount of many solvents, have a long processing time, and are not economically practical. From this point of view, this method is completely meaningless.

斯かる実状に詔いて、本発明者は、天然油脂から工業的
有利に1ePA又はそのエステルを収得せんと研究を行
い、エイコサペンタエン酸又はその誘導体を含む天然油
脂から得られる脂肪酸混合物を尿素処理して低不飽和脂
肪酸を除去し次いで分留を行う方法を見出し、先に特許
出願(%願昭56−75168号)した。
In view of these circumstances, the present inventor conducted research to industrially advantageously obtain 1ePA or its ester from natural oils and fats, and treated a fatty acid mixture obtained from natural oils and fats containing eicosapentaenoic acid or its derivatives with urea. They discovered a method of removing low unsaturated fatty acids and then performing fractional distillation, and filed a patent application (% Application No. 75168/1983).

この方法によると、低不飽和脂肪酸が尿素処理によって
ほとんど除去されているため、蒸留によってKPAを分
留する前の前音カットにほとんど時間がかからず、目的
とするmpムを高濃度で含有する主留を、変質させるこ
となく収得できるという利点を有する。しかし、その反
面、原料脂肪酸混合物を直ちに尿素処理に付すため、原
料に対し尿素を約1.5倍、アルコールを約10倍使用
することが必要であり、その結実装置が大きくなると共
に、操作も煩雑であり生成した大量の廃棄物の再生処理
が大へんであるという一点があった。
According to this method, most of the low unsaturated fatty acids are removed by urea treatment, so it takes almost no time to cut off the pre-tones before fractionating KPA by distillation, and it contains the target MPM at a high concentration. It has the advantage that the main residue can be obtained without deterioration. However, on the other hand, in order to immediately subject the raw fatty acid mixture to urea treatment, it is necessary to use approximately 1.5 times as much urea and approximately 10 times as much alcohol as the raw materials, which increases the size of the fruiting equipment and makes it difficult to operate. One problem was that it was complicated and it was difficult to recycle the large amount of waste generated.

そこで、本発明者は更に研究を行った結果、当該脂肪酸
混合物は、そのtt従来の蒸留、特にバッチ式蒸留に付
すと前音を除去してしまうまでに時間がかかり、IFム
の滞留加熱時間が長くなるため、EPAの熱変性がさけ
られないが、連続式でしかも加熱時間が短かくてすむ蒸
留装置を使用してEPA又はそのエステルを含む主留を
採取し、次いで尿素処理すれば、原料脂肪酸混合物の種
類によっては、高濃度のKPA又はそのエステルが得ら
れることを見出した。しかし、この方法においては、I
ICPAと分子量が近い高不飽和脂肪酸を多く含有する
当該脂肪酸混合物の場合には、次の尿素処理によっても
高不飽和脂肪酸を除去することかできす、EPAの濃度
を高めることはできない。そこで、更に検討を行ったと
ころ、I!iPAを多く含有する天然油脂の中で、ナン
キヨクオキアミ、ツノナシオキアミ、コペボーダ婢の動
物性海洋プランクトン、イワシ、サンマ、ニシン、サバ
等の青物魚の油脂はEPAと分子量が近い高不飽和脂肪
酸の含量が少なく、上記方法を適用するのに好都合であ
ることを見出した。
Therefore, as a result of further research, the present inventor found that when the fatty acid mixture is subjected to conventional distillation, especially batch distillation, it takes a long time to remove the foretone, and the residence heating time of the IF system increases. However, if the main distillate containing EPA or its ester is collected using a continuous distillation device that requires a short heating time, and then treated with urea, It has been found that depending on the type of raw fatty acid mixture, a high concentration of KPA or its ester can be obtained. However, in this method, I
In the case of a fatty acid mixture containing a large amount of highly unsaturated fatty acids with a molecular weight similar to that of ICPA, the subsequent urea treatment can only remove the highly unsaturated fatty acids, but cannot increase the concentration of EPA. So, after further consideration, I! Among the natural oils and fats that contain a large amount of iPA, oils and fats from Antarctic krill, horned krill, animal marine plankton from copeboda, and green fish such as sardines, saury, herring, and mackerel contain highly unsaturated fatty acids with a molecular weight close to that of EPA. It has been found that the content is small and it is convenient to apply the above method.

本発明は斯かる新知見に基いて完成されたもので、エイ
コサペンタエン酸又はその誘導体を含む天然油脂から得
られる脂肪酸混合物を連続式蒸留に付してエイコサペン
タエン酸又はそのエステルを40重量−以上含む主留を
採取し、次いでこれを尿素処理してエイコサペンタエン
酸又はそのエステルを製造する方法である。
The present invention has been completed based on this new knowledge, and involves subjecting a fatty acid mixture obtained from natural fats and oils containing eicosapentaenoic acid or its derivatives to continuous distillation to obtain eicosapentaenoic acid or its esters of 40% by weight or more. This is a method for producing eicosapentaenoic acid or its ester by collecting the main distillate containing the ester and then treating it with urea.

本発明の上記原料油脂は、常法に従ってケン化あるいは
アルコーリシスして、トリグリセライドを蒸留1こよる
分離を可能にするために遊離脂肪酸又は脂肪酸エステル
(本明細書においては、これら単独又は両者と合せて「
脂肪酸混合物」と称する)とする。
The above-mentioned raw material fats and oils of the present invention are saponified or alcoholized according to a conventional method, and free fatty acids or fatty acid esters (in this specification, these alone or together) are used to make it possible to separate triglycerides by distillation. hand"
(referred to as "fatty acid mixture").

本発明を′実施するには、まずこの脂肪酸混合物を蒸留
に付す。蒸留はEPAの滞留加熱時間が短かくてすむも
のでなければならず、そのためには連続式蒸留法が用い
られる。連続式蒸留はすでに公知の連続式蒸留装置を使
用できるが、その中でも、理論段数が6〜5の充填式又
はスプリング式の精留塔を2本組合わせ、その1本で前
音の除去を、他で主留の採取を行うのが好すしい@蒸留
は真空度5關与以下、好ましくは1諷階以下で行うのが
好ましく、例えば真空度約1■Hfにした場合、前音の
除去は180〜200℃の温度で40〜60分間行うこ
とによってなし得る。
To carry out the invention, the fatty acid mixture is first subjected to distillation. The distillation must require a short residence heating time for the EPA, and for this purpose a continuous distillation method is used. Continuous distillation can use already known continuous distillation equipment, but among these, two packed or spring-type rectification columns with a theoretical plate number of 6 to 5 are combined, and one of them can remove fore-tones. It is preferable to collect the main distillate elsewhere.@ Distillation is preferably carried out at a vacuum level of 5 degrees or less, preferably 1 degree or less.For example, when the vacuum degree is about 1 Hf, the Removal can be achieved by carrying out at a temperature of 180-200°C for 40-60 minutes.

次いで同真空度で200〜210°Cの温度で蒸留され
る部分を主留として採取する。主留の採取は40〜60
分間で終了する。この蒸留は可及的に滞留時間を短くす
るのが好ましく、そのためには広い沸点範囲のものを主
留として採取すればよいが、あまり主留の範囲が広いと
11iPA濃度が低くなり、次の尿素処理に付しても高
濃度のBPAを得ることができない。従って、主留はm
pム又はそのエステルを40重量%(以下チと記載する
)以上、特に好才しくは40〜609bを含むものを採
取するのが好適である。
Then, the part that is distilled at the same degree of vacuum and at a temperature of 200 to 210°C is collected as the main distillate. The main harvest is 40 to 60
Finishes in minutes. It is preferable to shorten the residence time of this distillation as much as possible, and for this purpose, it is sufficient to collect substances with a wide boiling point range as the main distillate, but if the range of the main distillate is too wide, the 11iPA concentration will be low, and the next Even with urea treatment, high concentrations of BPA cannot be obtained. Therefore, the main station is m
It is preferable to collect pm or its ester containing 40% by weight or more (hereinafter referred to as ``chi''), particularly 40 to 609b.

次いで、このようにして採取された主留は尿素処理に付
される。具体的には、尿素をこれをよく溶解する溶剤、
例えばメタノール、エタノール等に加え、必要ならば加
温して溶解させ、通常10〜20%の尿素溶液を調製す
る。これに脂肪酸混合物を加え攪拌する。この場合、溶
液中の尿素量は、主留1重量部(以下単に部として示す
)に対し0.5部以上、好ましくは1〜2部になるよう
−こ調整する。主留物を加えた尿素溶液は均一に混合す
る。
The main distillate thus collected is then subjected to urea treatment. Specifically, a solvent that dissolves urea well,
For example, in addition to methanol, ethanol, etc., if necessary, the urea is dissolved by heating to prepare a urea solution of usually 10 to 20%. Add the fatty acid mixture to this and stir. In this case, the amount of urea in the solution is adjusted to 0.5 parts or more, preferably 1 to 2 parts, per 1 part by weight of the main distillate (hereinafter simply expressed as parts). The urea solution with the main distillate is mixed uniformly.

次いで、この尿素処理液を冷却する。このとき混合脂肪
酸中の低不飽和脂肪酸は、析出する尿素の結晶に付加し
、一種の複合体となって分離される◎冷却方法は長時間
かけて放冷してもよいが、作業性の点から、冷却水勢を
使用して強制的ζこ冷却するのが好ましく、処理液の最
終温度を50℃以下、奸才しくは606C〜40℃とす
るのがよい結果を与える。
Next, this urea treatment liquid is cooled. At this time, the low unsaturated fatty acids in the mixed fatty acids are added to the precipitated urea crystals and separated as a kind of complex. ◎The cooling method may be left to cool for a long time, but this may reduce workability. From this point of view, it is preferable to perform forced cooling using a cooling water force, and it is preferable to set the final temperature of the treatment liquid to 50° C. or less, preferably 606° C. to 40° C., to give good results.

斯くして得られる低不飽和脂肪酸が付加した尿素の結晶
を戸別し、溶液を濃縮して大部分の溶剤を留去した後、
水およびn−へキサン勢の非極性港剤を加えて、残存す
る尿素は水層に、不飽和度の高い脂肪酸(高不飽和脂肪
酸と称する)は溶剤層に移行させる。水層と溶剤層は静
置することによって水層は下層に分離されるので、この
水層を捨て、上層の溶剤層を充分に水洗し、溶剤を留去
すれば高濃度のll1PA又はそのエステルが得られる
・更に水洗番こよって尿素が完全に除かれない場合には
、例えば水洗した醪剤層を希薄な酸の水溶 ・液で洗浄
する方法、或いは尿素と親和性の強いケイ酸、活性白土
、活性アルミナ、活性炭等の吸着剤勢を用いてバッチ式
あるいはカラム流下法によって尿素を吸着除去すること
もできる。
The urea crystals to which the low unsaturated fatty acids have been added are separated from each other, and the solution is concentrated to remove most of the solvent.
By adding water and a non-polar port agent such as n-hexane, the remaining urea is transferred to the water layer, and the highly unsaturated fatty acids (referred to as highly unsaturated fatty acids) are transferred to the solvent layer. When the aqueous layer and the solvent layer are allowed to stand, the aqueous layer is separated into the lower layer, so discard this aqueous layer, wash the upper solvent layer thoroughly with water, and distill off the solvent to obtain a high concentration of ll1PA or its ester. If the urea is not completely removed by washing with water, for example, the washed mulch layer may be washed with a dilute aqueous acid solution, or silicic acid, which has a strong affinity with urea, or active Urea can also be adsorbed and removed by a batch method or a column flow method using an adsorbent such as clay, activated alumina, or activated carbon.

叙上の如く、本発明によれば、大規模の装置を必要とす
ることなく簡単な操作で、70s以上の高濃度のKPA
又はそのエステルを製造でき、工(1)イワシ油を常法
により、ナトリウムエチラートを触媒としてアルコーリ
シスを行なって、脂肪酸エチルエステルの混合物を得た
。この混合物の主たる脂肪酸の組成をガスクロマトグラ
フィーにより調べたところ、表1(a)のごとくであっ
た。
As described above, according to the present invention, high-concentration KPA can be produced for 70 seconds or more with simple operation without requiring large-scale equipment.
Process (1) Sardine oil was subjected to alcoholysis using sodium ethylate as a catalyst to obtain a mixture of fatty acid ethyl esters. The composition of the main fatty acids in this mixture was investigated by gas chromatography, and the results were as shown in Table 1(a).

(―)  この脂肪酸混合物B4tを2塔充填式連続蒸
留装置の第1塔に14t/Hでフィードし、連続的に前
音を49.6t (59% )カット後引き続いて第2
塔に連続的にフィードし主留24 t (2B、5−)
を分取した。第1塔の理論段数は5段、充填物はハーフ
リングであり、塔頂の温度は195℃、滞留時間は45
分であった。また第2塔の理論段数は5段、充填物はス
プリングコイルであり、塔頂の温度は208°Cであり
、滞留時間は55分であった。ガスクロマトグラフィー
によれば、分取した主留の脂肪酸組成は表1(′b)の
ごとくであった。
(-) This fatty acid mixture B4t was fed into the first column of a two-column packed continuous distillation apparatus at a rate of 14t/H, and after continuously cutting off the fore-tone by 49.6t (59%), the second
Continuously feed the column to the main distillate 24 t (2B, 5-)
was separated. The number of theoretical plates in the first column is 5, the packing is half-ring, the temperature at the top of the column is 195℃, and the residence time is 45℃.
It was a minute. The number of theoretical plates in the second column was 5, the packing was a spring coil, the temperature at the top of the column was 208°C, and the residence time was 55 minutes. According to gas chromatography, the fatty acid composition of the separated main distillate was as shown in Table 1 ('b).

(−)次に反応タンク中で、70℃に加温したエタ/−
ル680tに尿素128kgを溶解させた後、(IIで
得た主留をプールしたもの85kgを添加後均−になる
ように攪拌してから37℃になるまで冷却して、尿素と
低不飽和脂肪酸エチルエステルとの複合体を析出させた
。析出した結晶を戸別し、p液を減圧で濃縮して大部分
のエタノールを除去した後、水425tとn−ヘキサン
425tを添加して尿素を水層に、エチルエステルをn
−ヘキサン層iこ移行させ、静置分離させて下層にくる
水層を除去し、n−ヘキサン層を850tの温湯(40
℃)で5回洗浄した。このヘキサン層を脱水後、内径1
0cm高さ271のケイ酸カラム−ζ線速80clL/
Hで通して精製した。カラム溶出液を減圧で濃縮し、n
−ヘキサンを留去して本発明脂肪酸エチルエステル55
ゆを得た。斯くして得られたものの脂肪酸組成をガスク
ロマトグラフィーで分析した結果は表1(C)の通りで
あった。
(-) Next, in the reaction tank, ether/- was heated to 70°C.
After dissolving 128 kg of urea in 680 t of urea, add 85 kg of the pooled main distillate obtained in step II, stir until evenly distributed, cool to 37°C, and dissolve urea and low unsaturation. A complex with fatty acid ethyl ester was precipitated.The precipitated crystals were separated, and the p liquid was concentrated under reduced pressure to remove most of the ethanol, and then 425 tons of water and 425 tons of n-hexane were added to convert urea into water. layer, add ethyl ester to n
- The n-hexane layer was transferred to 850 tons of warm water (40
℃) for 5 times. After dehydrating this hexane layer,
0 cm height 271 silicic acid column - ζ linear velocity 80 clL/
Purified by passing with H. The column eluate was concentrated under reduced pressure and n
- By distilling off hexane, the fatty acid ethyl ester of the present invention 55
I got it. The fatty acid composition of the product thus obtained was analyzed by gas chromatography, and the results are shown in Table 1(C).

以下余白 実施例2 (口 イサデアミ乾燥品よりn−へキサンで抽出した油
を常法によりケン化して脂肪酸混合物を得もガスクロマ
トグラフィー分析によれば、このものの脂肪酸組成は表
2(a)のごとくであった。
The following is a margin of Example 2 (1) A fatty acid mixture was obtained by saponifying the oil extracted with n-hexane from a dried product of Isadeami using a conventional method.According to gas chromatography analysis, the fatty acid composition of this product was shown in Table 2 (a). It was like that.

(雪)  この脂肪酸混合物591を実施例1の(1の
装置により前音34.2 t (58%)をカットし、
主留9.5 t (16To )を分取した。ガスクロ
マトグラフィーによれば、このものの脂肪酸組成は表2
(1)1のごとくであった〇 (ml  次に(1で得た主留100kgをプールし、
実施例1と同様の方法で尿素処理およびケイ酸カラム精
製を行なった後脱溶剤して本発明脂肪酸63kgを得た
。斯くして得られたものの脂肪酸組成をガスクロマトグ
ラフィーで分析した結果は表2(C)の通りであった。
(Snow) This fatty acid mixture 591 was cut off by 34.2 t (58%) using the apparatus of Example 1 (1).
A main distillate of 9.5 t (16 To) was collected. According to gas chromatography, the fatty acid composition of this product is shown in Table 2.
(1) It was as in 1〇(ml) Next, pooled 100 kg of the main distillate obtained in (1),
After urea treatment and silicic acid column purification in the same manner as in Example 1, the solvent was removed to obtain 63 kg of the fatty acid of the present invention. The fatty acid composition of the product thus obtained was analyzed by gas chromatography, and the results are shown in Table 2(C).

以下余白 表  2Margin below Table 2

Claims (1)

【特許請求の範囲】 +11  エイコサペンタエン酸又はその誘導体を含む
天然油脂から得られる脂肪酸混合物を連続式蒸留に付シ
てエイコサペンタエン酸又はそのエステルを40重量−
以上含む主留を採取し、次いでこれを尿素処理すること
を特徴とするエイコサペンタエン酸またはそのエステル
の製法。 (2)  主留がエイコサペンタエン酸又はそのエステ
ルを40〜60重量%含むものである特許請求の範囲第
1項記載の製法。
[Claims] +11 A fatty acid mixture obtained from natural fats and oils containing eicosapentaenoic acid or its derivatives is subjected to continuous distillation to obtain 40% by weight of eicosapentaenoic acid or its ester.
A method for producing eicosapentaenoic acid or its ester, which comprises collecting the main distillate containing the above and then treating it with urea. (2) The method according to claim 1, wherein the main distillate contains 40 to 60% by weight of eicosapentaenoic acid or its ester.
JP10320781A 1981-05-15 1981-07-03 Preparation of eicosapentaenoic acid or its ester Granted JPS588037A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP10320781A JPS588037A (en) 1981-07-03 1981-07-03 Preparation of eicosapentaenoic acid or its ester
US06/329,883 US4377526A (en) 1981-05-15 1981-12-11 Method of purifying eicosapentaenoic acid and its esters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10320781A JPS588037A (en) 1981-07-03 1981-07-03 Preparation of eicosapentaenoic acid or its ester

Publications (2)

Publication Number Publication Date
JPS588037A true JPS588037A (en) 1983-01-18
JPH0525870B2 JPH0525870B2 (en) 1993-04-14

Family

ID=14348061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10320781A Granted JPS588037A (en) 1981-05-15 1981-07-03 Preparation of eicosapentaenoic acid or its ester

Country Status (1)

Country Link
JP (1) JPS588037A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460917A2 (en) * 1990-06-04 1991-12-11 Nippon Suisan Kaisha, Ltd. Method of producing eicosapentaenoic acid or an ester derivative thereof
JPH0441457A (en) * 1990-06-04 1992-02-12 Nippon Suisan Kaisha Ltd Production of eicosapentaenoic acid or its ester
JPH04128250A (en) * 1990-06-04 1992-04-28 Nippon Suisan Kaisha Ltd Production of highly concentrated eicosapentaenoic acid or its ester
WO1993009210A1 (en) * 1991-10-28 1993-05-13 Nippon Suisan Kaisha, Ltd. Process for producing high-purity eicosapentaenoic acid or ester thereof
JP2010132631A (en) * 2008-11-04 2010-06-17 Bizen Chemical Co Ltd Composition having inverse agonist and antagonist activities of cannabinoid receptor
JP2011522913A (en) * 2008-05-15 2011-08-04 プロノヴァ バイオファーマ ノルゲ アーエス Krill oil processing method
JP2014514264A (en) * 2011-03-08 2014-06-19 コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Process for distillation of fatty acid esters

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149400A (en) * 1981-03-12 1982-09-14 Kureha Chemical Ind Co Ltd Manufacture of high purity long chain highly unsaturated fatty acid ester

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149400A (en) * 1981-03-12 1982-09-14 Kureha Chemical Ind Co Ltd Manufacture of high purity long chain highly unsaturated fatty acid ester

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460917A2 (en) * 1990-06-04 1991-12-11 Nippon Suisan Kaisha, Ltd. Method of producing eicosapentaenoic acid or an ester derivative thereof
JPH0441457A (en) * 1990-06-04 1992-02-12 Nippon Suisan Kaisha Ltd Production of eicosapentaenoic acid or its ester
JPH04128250A (en) * 1990-06-04 1992-04-28 Nippon Suisan Kaisha Ltd Production of highly concentrated eicosapentaenoic acid or its ester
WO1993009210A1 (en) * 1991-10-28 1993-05-13 Nippon Suisan Kaisha, Ltd. Process for producing high-purity eicosapentaenoic acid or ester thereof
US5840944A (en) * 1991-10-28 1998-11-24 Nippon Suisan Kaisha, Ltd. Method to produce highly pure eicosapentaenoic acid or its ester
JP2011522913A (en) * 2008-05-15 2011-08-04 プロノヴァ バイオファーマ ノルゲ アーエス Krill oil processing method
US8829215B2 (en) 2008-05-15 2014-09-09 Pronova Biopharma Norge As Krill oil process
JP2010132631A (en) * 2008-11-04 2010-06-17 Bizen Chemical Co Ltd Composition having inverse agonist and antagonist activities of cannabinoid receptor
JP2014514264A (en) * 2011-03-08 2014-06-19 コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Process for distillation of fatty acid esters

Also Published As

Publication number Publication date
JPH0525870B2 (en) 1993-04-14

Similar Documents

Publication Publication Date Title
US4377526A (en) Method of purifying eicosapentaenoic acid and its esters
JPH0159318B2 (en)
JPH11236591A (en) Preparation of highly pure eicosapentaenoic acid or its ester
JPS649977B2 (en)
JP2002180085A (en) Method for separating and purifying unsaturated fatty acid in high purity using crystallization method
Brown et al. Studies on the Chemistry of the Fatty Acids. I. The Purification of Linoleic Acid by Crystallization Methods1
JPH0225447A (en) Production of highly unsaturated fatty acids
JPS588037A (en) Preparation of eicosapentaenoic acid or its ester
Gunstone et al. Improved procedures for the isolation of pure oleic, linoleic, and linolenic acids or their methyl esters from natural sources
JPH08100191A (en) Purification of highly unsaturated fatty acid or ester thereof
JPH08218091A (en) Production of high-purity highly unsaturated fatty acid and its derivative
JP2003506423A (en) Recovery of polyunsaturated fatty acids from urea adduct
JPH0140817B2 (en)
JPH1180083A (en) Production of eicosapentaenoic ester
JP3040136B2 (en) Method for producing eicosapentaenoic acid or ester thereof
JPS6388159A (en) Production of docosahexaenoic acid ester
JPS62145099A (en) Separation and purification of cholesterol
JP3614177B2 (en) Method for producing high-purity docosahexaenoic acid or its ester
JPS59118740A (en) Preparation of eicosapentaenoic acid or its lower alcohol ester
GB2160874A (en) A process for producing carotene from oils and fats
JP3005638B2 (en) Method for producing high concentration eicosapentaenoic acid or ester thereof
JPH07110956B2 (en) Process for producing eicosapentaenoic acid or its ester and docosahexaenoic acid or its ester
FR2630730A1 (en) PROCESS FOR OBTAINING SQUALANE
JPH02268133A (en) Production of eicosapentaenoic acid or ester thereof
JPH01290659A (en) Production of natural carotene condensate